MP29-02*’s Advanced Delivery System Contributes to Its Efficacy in Patients With Moderate/Severe Seasonal Allergic Rhinitis

Clinical and Translational Allergy - United Kingdom
doi 10.1186/2045-7022-5-s4-p36
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search